Gene therapies for the cats and dogs you love? Penn-partnered Scout Bio just raised $20M to make it a reality

The gene therapy revolution that’s been sweeping through biotech isn’t just about humans anymore. A Penn-partnered biotech called Scout Bio has just picked up a $20 million round to step up its work on once-and-done therapies for common pet ailments.